HOME
Firmenprofil
OPERATIVE ONKOLOGIE
HIPEC – Hyperthermic IntraPeritoneal Chemotherapy
ISOLIERTE ORGAN PERFUSION
PERFORMER HT
PUBLIKATIONEN
Congresses – DE
Links – DE
PRODUKTE
Performer 3
Performer HT
SERVICE
PERFUSIONSSERVICE
MULTIMEDIA
F.A.Q.
Contacts – DE
SPRACHE
English
Français
Español
Italiano
Cost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy
Stephanie L.Lima, Laura J.Havrilesky, Ashraf S.Habib, Angeles Alvarez Secord
Prev
Next